Peking Union Medical College Hospital: Neoplasms trials

The registry lists 21 Neoplasms studies with Peking Union Medical College Hospital as lead sponsor. 13 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 3Phase 2 9No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related TumorsEnrolling by invitationNCT07822347Phase 1/2
• Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer CachexiaRecruitingNCT07670286
• Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related DiseasesRecruitingNCT07464132Phase 1/2
• Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune DiseaseRecruitingNCT07400224Phase 1/2
• 68Ga-NYM096 PET/CT in Various Kinds of CancerRecruitingNCT07144748Not applicable
• Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGDRecruitingNCT06638034Early Phase 1
• Establishing Prospective Mediastinal Tumor Database of PUMCHRecruitingNCT06421805
• 99mTc-CNDG Injection in the Diagnosis of Malignant TumorsRecruitingNCT06030817Not applicable
• Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6RecruitingNCT06028672Not applicable
• Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7RecruitingNCT06020755Phase 2
• BBPA PET/CT in Patients With Malignant TumorsRecruitingNCT05987098Not applicable
• MUC1 Therapeutic Tumor Vaccine in Advanced Solid CancersNot yet recruitingNCT05986981Phase 2
• A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous NeoplasmNot yet recruitingNCT05593393
• Quality Control of Colposcopy ApplicationCompletedNCT06823817
• RT for Cervical Adenocarcinoma/adenosquamous CarcinomaActive, not recruitingNCT06741046
• Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic NeoplasmsStatus unknownNCT05259384Not applicable
• Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine NeoplasmStatus unknownNCT05113355Phase 2
• Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant TumorsStatus unknownNCT04010071Phase 2
• Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCStatus unknownNCT03910712Phase 2
• Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsCompletedNCT03895970Phase 2
• Precise Treatment in Hepatobiliary Cancers (PTHBC)Status unknownNCT02715089